Alejandro Weinstein rejoins Gauzy’s board as company streamlines leadership

TEL AVIV - Gauzy Ltd. (NASDAQ:GAUZ), a provider of vision and light control technologies with a market capitalization of $115.64 million, announced Thursday that longtime investor Alejandro Weinstein has been elected to return to its Board of Directors, with his term set to begin November 1, 2025. According to InvestingPro data, the company faces financial challenges with negative EBITDA of -$22.62 million in the last twelve months.

Weinstein, who previously served as a director at Gauzy, brings over 30 years of managerial experience, including his tenure as CEO of CFR Pharmaceuticals S.A., which he led through a public listing and eventual multi-billion-dollar sale to Abbott Laboratories.

The company also announced the departure of two board members: Gal Gitter, whose term as a Class I Director expired, and Danny Allouche, who is stepping down after six and a half years of service.

"Alejandro brings invaluable experience as a CEO who successfully built a global leader in the pharmaceutical industry that went public under his leadership," said Eyal Peso, CEO and Chairman of Gauzy, in a statement.

Weinstein, who has been involved with Gauzy since 2016, stated: "As a longtime supporter of Gauzy, I continue to be inspired by its rapid expansion in the light and vision control market."

The board changes appear to be part of a broader effort to streamline leadership, with the company noting in its announcement that it is adopting a "leaner board to reduce corporate expenses and maintain agility."

Gauzy, headquartered in Tel Aviv with subsidiaries across multiple countries, serves clients in aeronautics, automotive, and architecture sectors in over 60 countries.

The information in this article is based on a company press release.

In other recent news, Gauzy Ltd. announced significant insider transactions involving its CEO and a major investor. CEO and Co-Founder Eyal Peso, along with director nominee Alejandro Weinstein, purchased a total of 560,000 ordinary shares from an existing investor in a private deal. This transaction, completed in the first half of June 2025, reflects strong confidence from Gauzy’s leadership. Peso financed his portion of the purchase through a personal loan, underscoring his commitment to the company’s future. Additionally, Gauzy clarified that it has no immediate plans to issue equity securities under its recently filed shelf registration. The Form F-3 registration, filed with the U.S. Securities and Exchange Commission, is intended to provide financial flexibility for potential future opportunities. These developments indicate strategic moves by Gauzy’s leadership and a focus on maintaining financial agility.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.